Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2003
03/05/2003EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series
03/05/2003EP1288216A1 Tricyclic quinazolinediones
03/05/2003EP1288214A1 Paroxetine methanesulfonate
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288202A1 N-acyltetrahydroisoquinoline derivatives
03/05/2003EP1287829A1 An ayurvedic preparation as a sedative, heart tonic compound and as a resistive urinary infection remedy
03/05/2003EP1287825A1 Blends comprising a substituted fatty acid or a derivative thereof
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287137A2 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
03/05/2003EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use
03/05/2003EP1287131A2 Regulator of g protein signalling (rgs8)
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287126A1 Ligands specific for an isoform of the prion protein
03/05/2003EP1287116A2 Neural progenitor cell populations
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1287002A1 Crf receptor antagonists
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286688A2 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs
03/05/2003EP1286687A2 A method of treatment of huntington's chorea with a protein extractable from mammalian organs
03/05/2003EP1286685A2 A method of treatment of parkinson's disease with a protein extractable from mammalian organs
03/05/2003EP1286683A2 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
03/05/2003EP1286672A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
03/05/2003EP1286659A2 Macromolecular drug complexes and compositions containing the same
03/05/2003EP1286590A2 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1109549B1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs
03/05/2003EP1079826B1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
03/05/2003EP1003706B1 Cyclohexenone long-chain alcohol and medicament containing same
03/05/2003EP0930070B1 Stable aspirin ointment preparations
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003EP0791009A4 Modified neuropeptide y receptors
03/05/2003EP0782441B1 Pharmaceutical control of inflammation
03/05/2003EP0754060B1 New combination of a beta-receptor blocker and a local anaesthetic
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0690863B1 Tetracyclic compounds as dopamine agonists
03/05/2003EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor
03/05/2003CN1400975A 嘌呤衍生物 Purine derivatives
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400904A Selective estrogen receptor modulators in combination with estrogens
03/05/2003CN1400901A Method for reducing or tliminating smoking
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400896A Ibuprofen containing active agent preparation
03/05/2003CN1400205A Preparation method of memantine hydrochloride
03/05/2003CN1399996A Liquor for dispelling the effects of alcohol
03/05/2003CN1399989A Naotong soluble preparation and its production method
03/05/2003CN1399987A Inhibition action of total alkali of equisetum pratense on central nervous system and its action mechanism
03/05/2003CN1399986A Medicine for curing sleepless
03/05/2003CN1399964A Capsule for curing facial paralysis and its preparation method
03/05/2003CN1399959A Etomidate fatty emulsion injection preparation method
03/05/2003CN1399916A Application of dihydromyricetin in preparation of food, cosmetics or medicine
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102407C Antidepressive capsule and preparing process thereof
03/05/2003CN1102402C Chinese herbal granule for curing headache and its preparing method
03/05/2003CN1102396C Production process of compound meilingzhihua health food series
03/05/2003CN1102390C Fase dissolving galanthamine hydrobromide tablet
03/05/2003CN1102386C Combination of 5-HT uptake inhibitor with selective 5-HT1A antagonist
03/05/2003CN1102385C Rapidly disintegrating medicinal form of tramadol or tramadol salt
03/04/2003US6528653 Thienopyrrolidinones
03/04/2003US6528649 Imidazoloisoquinolines
03/04/2003US6528533 Treating or preventing neuronal damage associated with neurological diseases; hydrazide based compounds containing the group -N-N-CO-X- where X is C,O,S,or N
03/04/2003US6528524 Treating the multiple drug resistance, arrhythmia, spasms and malaria; reacting hydrochloric acid with cinchonine or to cinchonine monohydrochloride in form cinchonine dihydrochloride; high purity
03/04/2003US6528522 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
03/04/2003US6528521 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
03/04/2003US6528518 Treatment of depression with kappa receptor antagonists
03/04/2003US6528512 Cytokine specific binding protein;
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528499 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
03/04/2003US6528306 Engraftable human neural stem cells
03/04/2003US6528271 Drug screening
03/04/2003US6528076 Acetone, a salicylate-based compound and an emollient.
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/27/2003WO2003016917A2 Sodium channel regulators and modulators
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016563A2 Novel molecular target for neurotoxicity
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016506A2 Secreted proteins
02/27/2003WO2003016493A2 Transporters and ion channels
02/27/2003WO2003016467A2 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass
02/27/2003WO2003016466A2 ANTI-Aβ ANTIBODIES
1 ... 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 ... 1833